Federal HB5355 aims to improve early detection and screening of pediatric liver diseases.
Federal HB5355, the Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act, mandates the Secretary of Health and Human Services to implement a public education program on early signs of pediatric liver disease. The bill also requires a study on the cost-effectiveness of adding direct-bilirubin as a screening test for biliary atresia and other cholestatic liver diseases to State newborn-screening panels. The study will also cover trends in pediatric liver-transplant wait-list mortality and the effectiveness of early-warning tools for cholestatic liver disease.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.